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We thank the authors of this letter for their positive comments on our work and 
contributions.  We point out that their comments in fact do not bear directly on the content of our 
review. The latter concerns effects of conduction change rather than recovery from excitation on 
arrhythmic behaviour.  Their comments concern readouts from the action potential recovery that 
follows. In this the authors express strong reservations concerning the use of monophasic action 
potential recordings. Our own view corresponds more closely to accepted and long established 
criteria for such measurements accurately reproducing waveform morphology and repolarization 
times of transmembrane APs (Knollmann et al., 2001) potentially translatable from studies in 
mouse to human hearts (Moore and Franz, 2007), that precede the account given by the 
correspondent (Tse et al., 2016c). All techniques possess limitations: however, available readouts 
of APD recovery under common conditions in fact show a close consistency in the papers quoted 
by the correspondent (Martin et al., 2010, Stokoe et al., 2007). This is evident in absolute values 
of APD70 in the left ventricles of WT heart paced at 8 Hz, summarized in the bar graphs of their 
Figure 9A and C (Stokoe et al., 2007) and Figure 4B (Martin et al., 2010) respectively. The first 
paper then achieves a statistical power to demonstrate significant changes with pharmacological 
challenge in the LV specifically. It did not explore other cardiac regions within the same 
preparation, but went on to segment the test, Scn5a
+/-
, hearts into subcategories by their different 
arrhythmic phenotypes. The second continues from the first and studied all LV and RV, 
endocardial and epicardial, regions often in the same heart, confirming concordant directions of 
change in all regions studied (Their figure 3A-F), and statistical significance in the RV 
epicardium, where such effects would therefore be greatest (Their figure 4B).  Furthermore, 
(Stokoe et al., 2007) sorted Scn5a
+/-
 hearts by arrhythmic property for detailed analysis relating 
these properties to refractory period. In contrast, (Martin et al., 2010) differently treated the 
Scn5a
+/-
 group of hearts together. Both papers meticulously reported all remaining APDx values, 
but the inferences concerning relative AP recovery timecourses in Scn5a
+/-
 and WT, before or 
after flecainide or quinidine challenge, particularly changes in the right ventricle epicardium 
relative to remaining regions remained the same.   
 
The correspondent does not seem to have noted our detailed description, controls and caveats in 
our Methods concerning electrode distances when measuring activation latencies. We draw his 
attention to p 1153, column 2 of the paper (Martin et al., 2010): ‘The stimulating electrode and 
the epicardial LV and RV recording electrodes were clamped at a constant position through all 
experiments. This was at a distance of approximately 10 mm between stimulating and each 
recording electrode, although it was slightly larger for the LV than for the RV. This distance 
allowed the hearts to be placed into the rig, with the stimulating electrode coming into contact 
with the septum and the recording electrodes coming into contact with the left and right 
ventricles. While the direct absolute distance between electrodes would not necessarily reflect 
the path through which the electrical signal would be conducted in the spherical whole heart, the 
fact that the distance was maintained between experiments allowed consistent measurements of 
activation latencies. As the clamp was secure throughout experiments, this distance was constant 
to ∼0.5 mm, i.e., 5% of the distance between stimulating and recording electrodes.’ and ‘ 
Activation latencies for MAPs recorded from the RV and LV epicardium were measured from 
the stimulus time to peak amplitude of the MAP to give an indication of conduction velocities. 
With the positions of the stimulating and recording electrodes constant between experiments, 
comparisons could be made between WT and Scn5a
+/−
 hearts, and before and after drug. 
However, as the distance from stimulating electrode on the septum was slightly greater to the LV 
recording electrode than the RV recording electrode, no direct comparison could be made 
between LV and RV.’(Martin et al., 2010). 
We agree with the correspondent’s view concerning the potential importance of 
propagation parameters as reflected in our experimental analysis concerning AP wavelength 
(Matthews et al., 2013), but do not regard this as a sole determinant of arrhythmic tendency. 
Thus: (1) within the Scn5a
+/-
 platform under discussion, Martin et al. (2010) had pointed out that: 
‘….Scn5a+/-  hearts showed slowed conduction times in both RV and LV, exacerbated not only 
by flecainide but also by quinidine, in contrast to their differing effects on arrhythmogenesis.’  
(2) We point out evidence for contributions from recovery, APD and refractoriness parameters in 
the Scn5a+/∆KPQ system modeling long QT as opposed to Brugada Syndrome in which the 
consequent increase in wavelength accompanied increased, and not decreased arrhythmic 
tendency (Sabir et al., 2007b, Sabir et al., 2007a).  (3) We point out situations of altered Ca
2+
 
homeostasis in which arrhythmic tendency appears to accompany normal conduction and action 
potential recovery (Hothi et al., 2008). (4) We point out that (Tse et al., 2016a) themselves report 
arrhythmic effects of hypokalaemia in an absence of altered conduction more consistent with (2) 
above rather than their own assertion related to conduction velocity.   
However, we then are unclear as to the grounds that the correspondents bases their 
assertion as this is based on quoted papers themselves solely dependent upon measures of 
recovery processes obtained from the very MAP electrode measurements, about which he 
expresses significant doubt. Similarly their quoted papers on analysis of restitution properties 
(Tse et al., 2016b, Tse et al., 2016a) were not based on the analysis of the kind we have 
previously described that tested for a central role of wavelength change in arrhythmia (Matthews 
et al., 2013). Rather they were based on analysis of MAP electrode-derived recovery (APD) data 
(Tse et al., 2016c, Tse et al., 2016d). Information about these processes would be required in 
order to reconstitute the wavelength term.  
We also agree with their suggestions concerning the usefulness of studies using 
complementary techniques, and draw attention to available multi-electrode recording studies on 
Scn5a
+/- 
(Martin et al., 2011, Zhang et al., 2014, Jeevaratnam et al., 2012, Jeevaratnam et al., 
2011) and other systems (Salvage et al., 2015). However these provide measures of propagation, 
and not recovery and in that respect do not ‘supplement findings from MAPs’ (Martin et al., 
2011). We also draw their attention to complementary transmembrane membrane potential 
studies we have indeed performed on the same systems (King et al., 2013). We look forward to 
corresponding reports on their own experimental platform in the near future. 
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